Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Harsha, David W., Frank M. Sacks, Eva Obarzanek, Laura P. Svetkey, Pao-Hwa Lin, George A. Bray, Mikel Aickin, Paul R. Conlin, Edgar R. Miller, and Lawrence J. Appel. “Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial..” Hypertension 43, no. 2 (February 2004): 393–98. https://doi.org/10.1161/01.HYP.0000113046.83819.a2.

PMID
14707154
Full Text

Ard, Jamy D., Steve C. Grambow, Di Liu, Cris A. Slentz, William E. Kraus, Laura P. Svetkey, and Laura P. PREMIER study. “The effect of the PREMIER interventions on insulin sensitivity..” Diabetes Care 27, no. 2 (February 2004): 340–47. https://doi.org/10.2337/diacare.27.2.340.

PMID
14747211
Full Text

Eisenstein, E. L., J. L. Sun, E. R. Delong, D. B. Mark, D. N. Reddan, L. P. Svetkey, L. A. Szczech, A. A. Tsiatis, and W. F. Owen. “Is coronary artery revascularization associated with, increased life expectancy in chronic kidney disease patients?.” In Journal of the American Society of Nephrology, 14:675A-675A. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

Craddick, Shirley R., Patricia J. Elmer, Eva Obarzanek, William M. Vollmer, Laura P. Svetkey, and Martha C. Swain. “The DASH diet and blood pressure..” Curr Atheroscler Rep 5, no. 6 (November 2003): 484–91.

PMID
14525682
Scholars@Duke

Ard, J. D., S. Grambow, D. Liu, C. Slentz, W. Kraus, and L. P. Svetkey. “The effect of the PREMIER interventions on insulin sensitivity.” In Circulation, 108:767–767. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

Ard, J. D., S. Grambow, L. Di, C. Slentz, W. Kraus, and L. P. Svetkey. “The effect of the PREMIER interventions on insulin sensitivity.” In Circulation, 108:S-S. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

Edinger, T. P., L. P. Svetkey, D. Dalal, and L. J. Appel. “The impact of comprehensive lifestyle changes and weight loss on markers of inflammation: Results from the PREMIER trial.” In Circulation, 108:722–23. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

Lin, Pao-Hwa, Fiona Ginty, Lawrence J. Appel, Mikel Aickin, Arline Bohannon, Patrick Garnero, Denis Barclay, and Laura P. Svetkey. “The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults..” J Nutr 133, no. 10 (October 2003): 3130–36. https://doi.org/10.1093/jn/133.10.3130.

PMID
14519796
Full Text

Obarzanek, Eva, Michael A. Proschan, William M. Vollmer, Thomas J. Moore, Frank M. Sacks, Lawrence J. Appel, Laura P. Svetkey, Marlene M. Most-Windhauser, and Jeffrey A. Cutler. “Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial..” Hypertension 42, no. 4 (October 2003): 459–67. https://doi.org/10.1161/01.HYP.0000091267.39066.72.

PMID
12953018
Full Text

Erlinger, Thomas P., William M. Vollmer, Laura P. Svetkey, and Lawrence J. Appel. “The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives..” Prev Med 37, no. 4 (October 2003): 327–33.

PMID
14507489
Scholars@Duke

Pages